Insider tradingForm 4
Travere Therapeutics, Inc. (TVTX) Insider Trading
17 open-market trades reported since Aug 19, 2026: 0 purchases worth $0 and 17 sales worth $80.1M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Eric M. Dube | CEO | 0 | $0 | 4 | $38.5M |
| Peter Heerma | EVP | 0 | $0 | 3 | $17.9M |
| William E. Rote | Chief Research Officer | 0 | $0 | 2 | $13.1M |
| Christopher R. Cline | CFO | 0 | $0 | 2 | $3.19M |
| Jula Inrig | EVP | 0 | $0 | 1 | $2.79M |
| Elizabeth E. Reed | General Counsel | 0 | $0 | 1 | $2.34M |
| Sandra Calvin | CAO | 0 | $0 | 1 | $335K |
| Jeffrey A. Meckler | Director | 0 | $0 | 1 | $1.35M |
| Gary A. Lyons | Director | 0 | $0 | 2 | $633K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 19 | Eric M. DubeCEO | ▼ SELL10b5-1 | $13.1M | |
| Sep 17 | Eric M. DubeCEO | ▼ SELL10b5-1 | $12.4M | |
| Sep 17 | Peter HeermaEVP | ▼ SELL10b5-1 | $11.0M | |
| Sep 17 | William E. RoteChief Research Officer | ▼ SELL10b5-1 | $7.15M | |
| Sep 17 | Eric M. DubeCEO | ▼ SELL10b5-1 | $7.01M | |
| Sep 17 | Peter HeermaEVP | ▼ SELL10b5-1 | $6.36M | |
| Sep 17 | William E. RoteChief Research Officer | ▼ SELL10b5-1 | $5.99M | |
| Sep 17 | Eric M. DubeCEO | ▼ SELL10b5-1 | $5.96M | |
| Sep 17 | Christopher R. ClineCFO | ▼ SELL10b5-1 | $3.15M | |
| Sep 17 | Jula InrigEVP | ▼ SELL10b5-1 | $2.79M | |
| Sep 17 | Elizabeth E. ReedGeneral Counsel | ▼ SELL10b5-1 | $2.34M | |
| Sep 17 | Peter HeermaEVP | ▼ SELL10b5-1 | $539K | |
| Sep 17 | Sandra CalvinCAO | ▼ SELL10b5-1 | $335K | |
| Sep 11 | Jeffrey A. MecklerDirector | ▼ SELL10b5-1 | $1.35M | |
| Sep 3 | Christopher R. ClineCFO | ▼ SELL | $43K | |
| Aug 19 | Gary A. LyonsDirector | ▼ SELL10b5-1 | $317K | |
| Aug 19 | Gary A. LyonsDirector | ▼ SELL10b5-1 | $316K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings